UnknownPhase 3

The Influence of Timing of Cabergoline Initiation on Prevention of OHSS

Egypt75 participantsStarted 2017-12-20

Plain-language summary

Study the effect of early cabergoline administration in prevention of occurrence or decreasing the severity of OHSS in patients undergoing intra cytoplasmic sperm injection.And its effect on oocyte maturation,fertilization and pregnancy rate..

Who can participate

Age range19 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female less than 35 years under going Intra cytoplasmic sperm injection cycle for infertility (tubal factor or un explained infertility). * 18 or more oocyte 11 mm in diameter and/or E2 is more than 4000 pg/ml at any day of the stimulation cycle before or at HCG trigger Exclusion Criteria: * patient with one ovary * patients already receiving cabergoline treatment * Severe Male factor infertility. * Thyroid dysfunction.

What they're measuring

Occurrence and severity of OHSS

Timeframe: 2 to 4weeks after trigger

Trial details

NCT IDNCT02620605

SponsorMona M Shaban

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12

Contact for this trial

Sherine H Gad Allah, MD

01097665573 sherinehosny@gmail.com

View on ClinicalTrials.gov More Ovarian Hyperstimulation Syndrome trials